Clinical Trial

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Coronary artery disease, or narrowing of the blood vessels that provide blood to the heart, is the most common cause of death in the United States and can be treated with either coronary bypass surgery or coronary stent placement. This study will evaluate outcomes, including death and quality of life, at 10 years in 1,500 patients with coronary disease who have already been randomized to either bypass surgery or stenting.
Trial Details
NCT Number NCT07308860
Lead Sponsor Stanford University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Coronary Artery Disease
Enrollment 1,500 participants
Start Date 2025-08-01
Primary Completion 2030-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-30